Загрузка...
Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor
INTRODUCTION: Many second-line treatments for advanced non-small-cell lung cancer (NSCLC) have been assessed in randomised controlled trials, but which treatments work the best remains unclear. Novel treatments are being rapidly developed. We need a comprehensive up-to-date evidence synthesis of all...
Сохранить в:
| Опубликовано в: : | BMJ Open |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4985872/ https://ncbi.nlm.nih.gov/pubmed/27489157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-011841 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|